Latest Investor Confidence News

Global Masters Fund Limited has released its quarterly report for Q3 2025, confirming steady convertible note conversions and a healthy loan-to-value ratio, underscoring its solid financial position and compliance.

Dicker Data has acknowledged the suspension of former CEO David Dicker following a confidential whistleblower complaint but maintains the event did not materially affect the company’s securities or leadership structure.

Omnia Metals Group has addressed ASX concerns over unusual trading activity, confirming receipt and forthcoming disclosure of assay results from its Salt Creek drilling program.

Whitefield Income Limited has announced fully franked monthly dividends of 0.583 cents per share for the final quarter of 2025, delivering an 8.0% annual yield based on its IPO price.

Harvest Technology Group has resolved a longstanding dispute over the Vos Shine vessel, receiving A$725,000 in settlement proceeds that will positively impact its financials.

Sultan Resources has completed a $1 million strategic placement at a premium, positioning itself for key acquisitions and exploration in Namibia and Western Australia.

ENRG Elements Ltd’s EELO securities have been suspended from trading by the ASX due to non-compliance with key listing rules, raising questions about the company’s regulatory standing.

St George Mining has secured A$72.5 million in institutional and strategic funding to advance its Araxá rare earths and niobium project in Brazil towards a final investment decision. The capital raise underscores the project's strategic importance amid tightening global critical minerals supply chains.

Locksley Resources has upgraded its U.S. trading status to the OTCQX Best Market, enhancing its visibility among American investors and reinforcing its strategic focus on critical minerals at the Mojave Project in California.

AdAlta Limited has raised up to A$0.5 million through a premium-priced private placement, bolstering its 'East to West' cellular immunotherapy strategy focused on advancing CAR-T therapies for solid cancers.

Immutep Limited has confirmed 30 mg as the optimal biological dose for its immunotherapy efti, following FDA approval of Project Optimus requirements. This milestone paves the way for the US launch of its pivotal Phase III lung cancer trial.

Peninsula Energy has completed a significant A$69.9 million equity raise backed by cornerstone investor Tees River Uranium Fund, alongside fully drawing its Davidson Kempner debt facility, setting the stage for accelerated uranium production at its Lance Project in Wyoming.